alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

** **

** **
| **Certification of CEO and CFO**                  |
|---------------------------------------------------|
| **Pursuant to 18 U.S.C. Section 1350,**           |
| **As Adopted Pursuant to**                        |
| **Section 906 of the Sarbanes-Oxley Act of 2002** |

 

 

 

In connection with the Quarterly Report on Form 10-Q of Real Estate Associates Limited VI (the "Partnership"), for the quarterly period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Steven D. Cordes, as the equivalent of the chief executive officer of the Partnership, and Stephen B. Waters, as the equivalent of the chief financial officer of the Partnership, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

 

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.

 

 
|   |      /s/Steven D. Cordes  |
|--------|----------------------------------------------------|
|   | Name: Steven D. Cordes                             |
|   | Date: August 14, 2009                              |
|   |                                               |
|   |      /s/Stephen B. Waters |
|   | Name: Stephen B. Waters                            |
|   | Date: August 14, 2009                              |

 

 

This certification is furnished with this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Partnership for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
gfed20150303_8k.htm




  

Exhibit 10.5

 

 

Written Description of 

2015 Executive Incentive Compensation Annual Plan - 

Chief Credit Officer

 

The following is a description of the material terms of the 2015 Executive Incentive Compensation Annual Plan (the “Plan”) that was adopted by the Compensation Committee (the “Committee”) of the Board of Directors of Guaranty Federal Bancshares, Inc. (the “Company”) with respect to the bonus payable to Sheri Biser, the Company’s Chief Credit Officer (the "Executive"), for 2015:

 

The Plan will pay a maximum of $67,600 of which fifty percent (50%) of the bonus amount will be paid in cash and fifty percent (50%) will be paid in the form of restricted stock grants. There are three possible levels of incentive awards: threshold (25%); target (50%); and maximum (100%). For any bonus amount to be paid, the threshold level of performance must be achieved. The bonus amount will be prorated for performance achievements between the threshold and target levels and between the target and maximum levels. The four performance measurements of the Company (and the weight given to each measurement) applicable to each award level are as follows: (i) revenue growth (20%); (ii) net interest margin (20%); (iii) pre-tax net income (30%); and (iv) non-performing assets to average total assets (30%). The following minimum criteria must all be satisfied before an award is paid under the Plan: (i) net income of the Company for calendar year 2015 of at least 75% of approved budget to receive full performance incentive and incentive will be reduced by 50% if Company achieves between 50% and 74.99% of budget net income; No incentive will be paid if net income is below 50% of budget; (ii) satisfactory audits as determined by the Board of Directors of the Company after review of findings from regulatory examination reports and applicable audits and reviews; (iii) the bank’s tier 1 leverage capital and total risk-based capital ratios must not fall below 9% and 12%, respectively, and adversely classified assets to tier 1 capital and allowance for loan losses must not exceed 35%; and (iv) satisfactory performance appraisal, actively employed by Guaranty Bank, and in good standing at the time the bonus is paid, which will not be prior to the public release of earnings in 2016 for the calendar year 2015. The Board of Directors of the Company retains the right to make the final determination of the bonus payment and amount, if any, and may consider other pertinent facts prior to making an award of restricted stock. All incentive payments shall be subject to the Company’s Compensation Clawback Policy.

 

The Plan also includes vesting and holding periods for the restricted stock grants. The vesting period for these grants shall be three (3) years from the date of grant. Also, the Executive agrees not to sell, transfer or otherwise dispose of such shares for a period of three (3) years from the date of the award. Exceptions to such restriction on sale, transfer or disposition may be granted for hardship circumstances to be determined by the Committee.
[Federal Register Volume 86, Number 123 (Wednesday, June 30, 2021)]
[Notices]
[Page 34770]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13967]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2021-P-0424]


Medical Devices; Exemption From Premarket Notification: Powered 
Patient Transport, All Other Powered Patient Transport

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
announcing receipt of a petition requesting exemption from the 
premarket notification requirements. The document was published with an 
incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Dan Reed, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, Rm. 1526, Silver Spring, MD 20993-0002, 240-402-4717.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 15, 2021 (86 
FR 31722), in FR Doc. 2021-12505, on page 31722, the following 
correction is made:
    On page 31722, in the second column, in the header of the document, 
and, also on page 31723, in the first column under ``Instructions,'' 
``Docket No. FDA-2021-N-0493'' is corrected to read ``Docket No. FDA-
2021-P-0424''.

    Dated: June 25, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-13967 Filed 6-29-21; 8:45 am]
BILLING CODE 4164-01-P
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Northeast Area
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        
                Northeast Area Cities

                    Washington, D.C.
                            Newark, Delaware
                            Boston, Massachusetts
                            Beltsville, Maryland (BHNRC)
                            Beltsville, Maryland (BARC)
                            Frederick, Maryland
                            Orono, Maine
                            Geneva, New York
                            Ithaca, New York
                            University Park, Pennsylvania
                            Wyndmoor, Pennsylvania
                            Kearneysville, West Virginia
                            Leetown, West Virginia
                            Burlington, Vermont


                    Civil Rights & EEO Policy StatementsSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Docs SH&E







Ergonomic Programsheadline bar Ergonomics Resources and Information   NIH Health & Safety Guide to Laboratory Ergonomics  ? CDC Ergonomics Information  ?


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, September 22, 2015.

I certify that the above is a true extract from the minutes of

the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, September 22, 2015

The Court of Appeals hereby passes the following order

A16I0031. PROGRESSIVE MOUNTAIN INSURANCE COMPANY v. JAMES BISHOP.

Upon consideration of the Application for Interlocutory Appeal, it is ordered that it be

hereby GRANTED. The Appellant may file a Notice of Appeal within 10 days of the date of this

order. The Clerk of Superior Court is directed to include a copy of this order in the record

transmitted to the Court of Appeals.

LC NUMBERS:

2014RCCV00679
#### The People of the State of New York, Respondent, v Anthony Bonneau, Appellant.

[941 NYS2d 765]

Mercure, A.P.J.

Appeal from a judgment of the County Court of Greene County (Pulver Jr., J.), rendered July 20, 2010, upon a verdict convicting defendant of the crime of grand larceny in the third degree.

The victim contracted with defendant, an auctioneer, to sell various pieces of her grandfather’s artwork. Defendant was required to remit the net proceeds — over $27,000 — to the victim no more than 15 days after the sale. He failed to do so and, as a result, was charged in an indictment with grand larceny in the *1159third degree. Following a jury trial, defendant was convicted as charged, sentenced to a prison term of 2Vs to 7 years, and ordered to pay restitution. He appeals and we now affirm.

Defendant argues that the weight of the evidence adduced at trial does not support the jury’s finding that he possessed the requisite “intent to deprive [the victim] of property or to appropriate the same to himself or to a third person” (Penal Law § 155.05 [1]; *see*§ 155.35 [1]). It is undisputed, however, that the sale proceeds belonged to the victim, but defendant nevertheless converted them to his own use *(see People v Neiss,*128 AD2d 901, 901 [1987], *lv denied*70 NY2d 802 [1987]). Specifically, defendant deposited the funds into his general business account and, despite the victim’s repeated demands for payment, he paid business expenses and debts with the funds. Defendant thus “exercised dominion and control over the [victim’s] property in a manner wholly inconsistent with” her rights *(id.)*and, as such, the jury’s determination that he intended to deprive her of the auction proceeds is not against the weight of the evidence *(see People v Robinson,*284 NY 75, 80-81 [1940]; *People v Horney,*103 AD2d 891, 893 [1984]).

Defendant next contends that County Court erred in permitting the People to cross-examine him regarding his prior convictions of disorderly conduct, criminal trespass in the second degree and issuing a bad check, as well as a probation violation. While these crimes and prior bad acts were not committed recently, that fact alone did not require their preclusion *(see People v Walker,*83 NY2d 455, 459 [1994]; *People v Jones,*70 AD3d 1253, 1254 [2010]). Rather, in light of defendant’s claim that he was an honest businessman who had no intention of permanently depriving the victim of her property, these prior acts, raising issues of “individual dishonesty [ ] or untrustworthiness,” had “a very material relevance, *whenever committed” (People v Sandoval,*34 NY2d 371, 377 [1974] [emphasis added]; *accord People v Lemke,*58 AD3d 1078, 1078-1079 [2009]). Inasmuch as the probative value of this evidence outweighed the potential for prejudice, we perceive no abuse of discretion in County Court’s *Sandoval*ruling *(see People v Sandoval,*34 NY2d at 378; *People v Jones,*70 AD3d at 1254-1255).

Defendant’s remaining claim has been examined and found to be without merit.

Lahtinen, Spain, Stein and McCarthy, JJ., concur. Ordered that the judgment is affirmed.
#### The People of the State of New York, Respondent, v Billy Taylor, Appellant.

Judgment, Supreme Court, New York County (Thomas Galligan, J.), rendered on July 13, 1983, unanimously affirmed. Application by appellant’s counsel to withdraw as counsel is granted.,(See, *Anders v California,*386 US 738; *People v Saunders,*52 AD2d 833.) We have reviewed this record and agree with appellant’s assigned counsel that there are no nonfrivolous points which could be raised on this appeal. Concur — Sandler, J. P., Carro, Asch, Lynch and Ellerin, JJ.
# Uradni list C 134I/2022

| | ISSN 1977-1045 |
| --- | --- |
| Uradni list
  Evropske unije | C 134I |
| | |
| Slovenska izdaja | Informacije in objave | Letnik 6525. marec 2022 |

ISSN 1977-1045

Uradni list

Evropske unije

C 134I

Slovenska izdaja

Informacije in objave

Letnik 6525. marec 2022

---

| Vsebina | Stran |
| --- | --- |
| | IV   Informacije |
| | INFORMACIJE INSTITUCIJ, ORGANOV, URADOV IN AGENCIJ EVROPSKE UNIJE |
| | Evropska komisija |
| 2022/C 134 I/01 | Povzetek sklepov Evropske unije o dovoljenjih za promet z zdravili z dne 25. marca 2022
  (Objavljeno v skladu s členom 13 ali členom 38 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta) | 1 |

Vsebina

Stran

IV   Informacije

INFORMACIJE INSTITUCIJ, ORGANOV, URADOV IN AGENCIJ EVROPSKE UNIJE

Evropska komisija

2022/C 134 I/01

Povzetek sklepov Evropske unije o dovoljenjih za promet z zdravili z dne 25. marca 2022
  (Objavljeno v skladu s členom 13 ali členom 38 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta)

(Objavljeno v skladu s členom 13 ali členom 38 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta

1

---

| SL | |
| --- | --- |

SL

---

IV Informacije

INFORMACIJE INSTITUCIJ, ORGANOV, URADOV IN AGENCIJ EVROPSKE UNIJE

Evropska komisija

| 25.3.2022 | SL | Uradni list Evropske unije | CI 134/1 |
| --- | --- | --- | --- |

25.3.2022

SL

Uradni list Evropske unije

CI 134/1

---

Povzetek sklepov Evropske unije o dovoljenjih za promet z zdravili z dne 25. marca 2022

(Objavljeno v skladu s členom 13 ali členom 38 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta (1))

(2022/C 134 I/01)

| — | Izdaja dovoljenja za promet (člen 13 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta): Odobrena













  Datum sprejetja sklepa | Ime zdravila | INN (mednarodno nelastniško ime) | Imetnik dovoljenja za promet | Registracijska številka v registru Skupnosti | Farmacevtska oblika | ATC (anatomsko terapevtska kemijska oznaka) | Datum obvestila |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 25.3.2022 | EVUSHELD | tiksagevimab / cilgavimab | AstraZeneca AB
  151 85 Södertälje, Sverige | EU/1/22/1651 | Rztopina za injiciranje | J06BD03 | 25.3.2022 |

—

Izdaja dovoljenja za promet (člen 13 Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta): Odobrena

Datum sprejetja sklepa

Ime zdravila

INN (mednarodno nelastniško ime)

Imetnik dovoljenja za promet

Registracijska številka v registru Skupnosti

Farmacevtska oblika

ATC (anatomsko terapevtska kemijska oznaka)

Datum obvestila

25.3.2022

EVUSHELD

tiksagevimab / cilgavimab

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/22/1651

Rztopina za injiciranje

J06BD03

25.3.2022

Kdor želi dobiti vpogled v javno poročilo o oceni zadevnih zdravil ter o zadevnih sklepih o zdravilih, se lahko obrne na naslov:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  UL L 136, 30.4.2004, str. 1.

---
**EXHIBIT 32.2****SECTION 1350 CERTIFICATION of CHIEF FINANCIAL OFFICER**The undersigned herby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and inconnection with this Quarterly Report on Form 10-Q, that:**•** the report fully complies with the requirements of Sections 13(a)or 15(d), as applicable, of the Securities Exchange Act of 1934,as amended, and **•** the information contained in the report fairly presents, in allmaterial respects, the Company’s financial condition and resultsof operation.The foregoing certification is being furnished solely pursuant to 18U.S.C. Section 1350 and is notbeing filed as part of the report or as a separate disclosure document.   /s/ JoAnn N. McMinn   JoAnn N. McMinn, Chief Financial Officer       Dated: 11-08-2005       
28
---

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kenneth Hicks, President of Argentex Mining Corporation,
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | the Annual Report on Form 10-K of Argentex Mining
      Corporation for the year ended January 31, 2009 (the "Report") fully
      complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                                                                                              
|(2) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of Argentex Mining Corporation.                                                             

Dated: May 1, 2009



| | /s/
      Kenneth Hicks      
| | -----------------------------
| | Kenneth Hicks                
| | President                    
| | (Principal Executive Officer)
| | Argentex Mining Corporation  



A signed original of this written statement required by Section
906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Argentex Mining
Corporation and will be retained by Argentex Mining Corporation and furnished to
the Securities and Exchange Commission or its staff upon request.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice: 11456]

# SUMMARY:

The Department of State announces the renewal of the Charter for the International Security Advisory Board (ISAB). The purpose of the Secretary's International Security Advisory Board (ISAB) is to provide the Department with a continuing source of independent insight, advice, and innovation on all aspects of arms control, disarmament, nonproliferation, outer space, critical infrastructure, cybersecurity, the national security aspects of emerging technologies, and international security, as well as related aspects of public diplomacy. The ISAB will remain in existence for two years after the filing date of the Charter unless terminated or renewed.

      ( print page 35375)    

# FOR FURTHER INFORMATION CONTACT:

Neil Couch, Executive Director of the International Security Advisory Board, Department of State, Washington, DC 20520, telephone: (202) 647-0902.

Authority:5 U.S.C. Appendix and 41 CFR 102-3.65.

Johnny Neil Couch,

Executive Director, International Security Advisory Board, U.S. Department of State.

[FR Doc. 2021-14189 Filed 7-1-21; 8:45 am]

BILLING CODE 4710-35-P
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**838 CA 14-02124**  PRESENT: CENTRA, J.P., CARNI, LINDLEY, AND DEJOSEPH, JJ.

CHERYL VOSS AND GREGORY VOSS, PLAINTIFFS-RESPONDENTS,

V MEMORANDUM AND ORDER

JEFFREY DUCHMANN, DOING BUSINESS AS TRADE WINDS TENT & PARTY RENTAL, DEFENDANT-APPELLANT.

KENNEY SHELTON LIPTAK NOWAK LLP, BUFFALO (MICELLE M. RAGUSA OF COUNSEL), FOR DEFENDANT-APPELLANT.

PAUL WILLIAM BELTZ, P.C., BUFFALO (BRIAN R. HOGAN OF COUNSEL), FOR PLAINTIFFS-RESPONDENTS.

Appeal from an order of the Supreme Court, Erie County (Joseph R. Glownia, J.), entered April 9, 2014. The order, insofar as appealed from, denied the motion of defendant to compel discovery responses from plaintiffs.
It is hereby ORDERED that the order so appealed from is unanimously affirmed without costs.

Memorandum: “It is well settled that a court is vested with broad discretion to control discovery and that the court’s determination of discovery issues should be disturbed only upon a showing of clear abuse of discretion” ( Roswell Park Cancer Inst. Corp. v Sodexo Am., LLC , 68 AD3d 1720, 1721). We perceive no such abuse of discretion in Supreme Court’s denial of that part of the motion of defendant seeking to compel plaintiffs to provide authorizations permitting disclosure of the billing records of plaintiffs’ private health care insurers. Plaintiffs previously had provided authorizations permitting defendant to obtain the billing records of the health care providers of Cheryl Voss, the injured plaintiff, and defendant “failed to show the relevancy of the demanded documents” to its defense ( Jordan v Blue Circle Atl. , 296 AD2d 752, 753).

Entered: June 19, 2015 Frances E. Cafarell Clerk of the Court